Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 294, Issue 1-2, 2010, Pages 92-94

  Roghani, Mehrzad ^a   Mahboudi, Fereidoun ^b   Saharian, Mohammad Ali ^c   Etemadifar, Masoud ^d   Esfahani, Ali Naji ^e   Nahrevanian, Hossein ^b   Elahi, Elahe ^a,f  

^a UNIVERSITY OF TEHRAN   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Iran)

^f University of Rehabilitation Sciences   (Iran)

Author keywords

Iran; MS; Multiple sclerosis; Nitric oxide; NO; Serum NO

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; BODY FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; IRAN; MALE; MEASUREMENT; METABOLITE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; IRAN; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NITRIC OXIDE;

EID: 77953289563     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.03.024     Document Type: Article

References (34)

1. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31 (1999) 577-596
2. Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 111 (2003) 769-778
3. In: Ignarro L.J. (Ed). Nitric Oxide: Biology and Pathobiology. edn 1 ed. (2000), Academic Press, San Diego
4. Parkinson J.F., Mitrovic B., and Merrill J.E. The role of nitric oxide in multiple sclerosis. J Mol Med 75 (1997) 174-186
5. Touil T., Deloire-Grassin M.S., Vital C., et al. In vivo damage of CNS myelin and axons induced by peroxynitrite. NeuroReport 12 (2001) 3637-3644
6. Mac Micking J.D., Willenberg D.O., Weidemann M.J., et al. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis. J Exp Med 176 (1992) 303-307
7. Gonsette R.E. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 274 (2008) 48-53
8. Encinas J.M., Manganas L., and Enikolopov G. Nitric oxide and multiple sclerosis. J Clin Neurosci 9 5 (2002) 530-532
9. Smith K.J., and Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1 (2002) 232-241
10. Cross A.H., Manning P.T., Keeling R.M., et al. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 88 (1998) 45-56
11. Liu J.S., Zhao M.L., Brosnan C.F., et al. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 158 (2001) 2057-2066
12. Oleszak E.L., Zaczynska E., Bhattacharjee M., et al. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin Diagn Lab Immunol 5 (1998) 438-445
13. De Groot C.J., Ruuls S.R., Theeuwes J.W., et al. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 56 (1997) 10-20
14. Hill K.E., Zollinger L.V., Watt H.E., et al. Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 151 (2004) 171-179
15. Hooper D.C., Bagasra O., Marini J.C., et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 94 (1997) 2528-2533
16. Acar G., Idiman F., Idiman E., et al. Nitric oxide as an activity marker in multiple sclerosis. J Neurol 250 (2003) 588-592
17. Danilov A.L., Andersson M., Bavand N., et al. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 136 (2003) 112-118
18. Svenningsson A., Petersson A.S., Andersen O., et al. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course. Neurology 53 (1999) 1880-1882
19. Yamashita T., Ando Y., Obayashi K., et al. Changes in nitrite and nitrate (NO2-/NO3-) levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurol Sci 153 (1997) 32-34
20. Giovannoni G., Heales S.J., Silver N.C., et al. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci 145 (1997) 77-81
21. Nazliel B., Taskiran D., Irkec C., et al. Serum nitric oxide metabolites in patients with multiple sclerosis. J Clin Neurosci 9 (2002) 530-532
22. de Bustos F., Navarro J.A., de Andres C., et al. Cerebrospinal fluid nitrate evels in patients with multiple sclerosis. Eur Neurol 41 (1999) 44-47
23. Peltola J., Ukkonen M., Moilanen E., et al. Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy. Neurology 57 (2001) 895-896
24. Amirzargar A., Mytilineos J., Scherer S., et al. Anilysis Of HLA, DRB1,DRB2,DRB3,DQB1 AND DQA1 frequencies and haplotypes in 43 Iranian multiple sclerosis patients. 19th World Congress of Neurology, Free Paper Abstracts /. J Neurol Sci 285 (2009) S1(S57-S154):S57-S154S57-S
25. Kalanie H., Kholghie Y., Shamsai G.R., et al. Opticospinal multiple sclerosis in Iran. J Neurol Sci 276 (2009) 130-132
26. Kalanie H., Gharagozli K., and Kalanie A.R. Multiple Sclerosis. Report on 200 cases from Iran. Mult Scler 9 (2003) 36-38
27. Etemadifar M., Maghzi A.H., Sadrearhami S., et al. Late onset multiple sclerosis in Isfahan, Iran. J Neurol Sci 19th World Congress of Neurology (2009)
28. Al-Araji A., and Mohammed A.I. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?. J Neurol Sci 234 (2005) 67-71
29. Kurtzke J.F. Epidemiological evidence for multiple sclerosis as an infection. Clin Microbiol Rev 6 (1993) 382-427
30. Sahraian M.A., Khorramnia S., Moinfar Z., et al. Multiple sclerosis in Iran, demographic study of 8000 patients and changes over time. J Neurol Sci 19th World Congress of Neurology (2009)
31. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 1 (2001) 121-127
32. Hevel J.M., and Marietta M.A. Nitric-oxide synthase assays. Meth Enzymol 233 (1994) 250-258
33. McCarthy. The gender gap in autoimmune disease. Lancet 356 (2000) 1088
34. Giovannoni G. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis. Mult Scler 4 (1998) 27-30